Mostrar el registro sencillo del ítem

dc.contributor.authorBlesa, Javier
dc.contributor.authorInoue, Ken-Ichi
dc.contributor.authorGasca-Salas, Carmen
dc.contributor.authorBalzano, Tiziano
dc.contributor.authorReinares-Sebastián, Alejandro
dc.contributor.authorEsteban-García, Noelia
dc.contributor.authorRodríguez-Rojas, Rafael
dc.contributor.authorMárquez, Raquel
dc.contributor.authorCiorraga, María
dc.contributor.authorDel Álamo, Marta
dc.contributor.authorGarcía-Cañamaque, Lina
dc.contributor.authorRuiz de Aguiar, Santiago
dc.contributor.authorRachmilevitch, Itay
dc.contributor.authorTrigo-Damas, Inés
dc.contributor.authorTakada, Masahiko
dc.contributor.authorPineda-Pardo, José A.
dc.contributor.authorObeso, José
dc.contributor.authorLopez-Gonzalez del Rey, Natalia
dc.date.accessioned2025-01-18T15:04:24Z
dc.date.available2025-01-18T15:04:24Z
dc.date.issued2023
dc.identifier.citationBlesa, J., Pineda-Pardo, J. A., Inoue, K. I., Gasca-Salas, C., Balzano, T., Del Rey, N. L. G., ... & Obeso, J. A. (2023). BBB opening with focused ultrasound in nonhuman primates and Parkinson’s disease patients: Targeted AAV vector delivery and PET imaging. Science Advances, 9(16), eadf4888. https://doi.org/10.1126/sciadv.adf4888es
dc.identifier.issn2375-2548
dc.identifier.otherhttps://www.science.org/doi/10.1126/sciadv.adf4888?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmedes
dc.identifier.urihttp://hdl.handle.net/20.500.12020/1525
dc.description.abstractIntracerebral vector delivery in nonhuman primates has been a major challenge. We report successful blood-brain barrier opening and focal delivery of adeno-associated virus serotype 9 vectors into brain regions involved in Parkinson's disease using low-intensity focus ultrasound in adult macaque monkeys. Openings were well tolerated with generally no associated abnormal magnetic resonance imaging signals. Neuronal green fluorescent protein expression was observed specifically in regions with confirmed blood-brain barrier opening. Similar blood-brain barrier openings were safely demonstrated in three patients with Parkinson's disease. In these patients and in one monkey, blood-brain barrier opening was followed by 18F-Choline uptake in the putamen and midbrain regions based on positron emission tomography. This indicates focal and cellular binding of molecules that otherwise would not enter the brain parenchyma. The less-invasive nature of this methodology could facilitate focal viral vector delivery for gene therapy and might allow early and repeated interventions to treat neurodegenerative disorders.es
dc.language.isoenes
dc.publisherAmerican Association for the Advancement of Sciencees
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleBBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients: Targeted AAV vector delivery and PET imaginges
dc.typearticlees
dc.identifier.doihttps://doi.org/10.1126/sciadv.adf4888
dc.issue.number16es
dc.journal.titleScience Advanceses
dc.page.initialeadf4888es
dc.page.final-es
dc.rights.accessRightsopenAccesses
dc.subject.areaCiencias Biomédicases
dc.subject.keywordParkinson's Diseasees
dc.subject.keywordGene Therapyes
dc.subject.keywordFocused Ultrasoundes
dc.subject.unesco32 Ciencias Médicases
dc.volume.number9es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional